Adherence to CRC Screening and Surveillance Guidelines when Using Split-Dose Bowel Preparation
Table 3
Distribution of bowel preparation-related variables by whether physician recommendation was guideline compliant or not ().
Bowel preparation characteristics
Compliant ()
Noncompliant ()
Total ()
valuea
BBPS total score
BBPS ≥ 6
374 (94.9)
52 (83.9)
426 (93.4)
BBPS = 5
3 (0.76)
7 (11.3)
10 (2.1)
BBPS < 5
17 (4.3)
3 (4.8)
20 (4.3)
<0.001
BBPS segment score
2 or greater for each segment
371 (94.2)
45 (72.6)
416 (91.2)
0/1 in any segment
23 (5.8)
17 (27.4)
40 (8.8)
<0.001
Aronchick scale
Excellent/good prep quality
333 (86.7)
29 (49.2)
362 (79.3)
Fair prep quality
35 (9.1)
28 (47.5)
63 (13.8)
Inadequate/poor prep quality
16 (4.2)
2 (3.4)
18 (3.9)
<0.001
Noncompliance to split-dose preparation
54 (13.7)
17 (27.4)
385 (84.4)
0.006
Number of polyps
0
207 (52.5)
28 (45.2)
235 (51.5)
1
95 (24.1)
8 (12.9)
103 (22.6)
2
43 (10.9)
6 (9.7)
49 (10.8)
3
19 (4.8)
8 (12.9)
27 (5.9)
4
12 (3.1)
5 (8.1)
17 (3.7)
≥5
18 (4.6)
7 (11.3)
25 (5.5)
0.004
Endoscopy suite
Ambulatory surgery centers
184 (46.7)
24 (38.7)
208 (45.6)
Academic hospital unit
210 (53.3)
38 (61.3)
248 (54.4)
0.24
First colonoscopy
250 (63.8)
36 (58.1)
286 (63.0)
0.39
Had ≥2 previous colonoscopies
29 (7.4)
14 (22.6)
43 (9.5)
<0.001
Followed laxative instructions exactly
264 (67.0)
37 (60.0)
301 (66.0)
0.26
Bowel prep type
PEG
143 (36.5)
24 (38.7)
167 (36.8)
MiraLAX®/Gatorade®
226 (57.7)
37 (59.7)
263 (57.9)
Otherb
23 (5.9)
1 (1.6)
24 (5.3)
0.38
Colonoscopy appointment was before 10:30 am.
193 (49.0)
22 (35.5)
215 (47.2)
0.05
>12 hours or never till clear BM
139 (35.6)
30 (49.2)
169 (37.5)
0.04
All values are N (% of split-dose compliant or % of split-dose noncompliant), unless otherwise specified. aPlease see footnote under Table 2. bIncludes sodium phosphate/Osmoprep, Half-Lytely, Moviprep, and 2-day prep.
